Early Administration of L-carnitine in Hemodialysis Patients

Mise à jour : Il y a 4 ans
Référence : NCT00322322

Femme et Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Hemodialysis is a cause of carnitine deficiency. The deficiency of carnitine induces an anemia by an increase fragility of the red blood cells, a muscular fatigue and a cardiac dysfunction. We proposed to evaluate the benefit of an early administration of L-carnitine in hemodialysis patients. The patients should be included in the first month after the start of chronic hemodialysis, randomized to receive L-carnitine or placebo and should be followed-up during one year.


Critère d'inclusion

  • Complication of Hemodialysis ,Hyperthyroidism Treated or Under Control

Liens